Arcline Sells American Holt and Pride Engineering to ProMach

Arcline Investment Management (“Arcline), a growth-oriented private equity firm, today announced that it has sold its portfolio companies American Holt and Pride Engineering (collectively “AmHolt”) to ProMach. With facilities in Massachusetts, Quebec, and Minnesota, AmHolt is a collection of leading brands that provide engineered aftermarket parts and consumables to the food and beverage packaging and […]

Shopley Announces Steve Levely as Chief Executive Officer

TORONTO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Shopley Inc. (the “Company” or “Shopley“), an interactive commerce solution provider for merchants and merchant services providers, is pleased to announce the appointment of Mr. Steve Levely to the position of Chief Executive Officer. The appointment of Steve Levely as CEO represents a deliberate step in positioning Shopley

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NYSE:ARE), LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or “the Company”) (NYSE: ARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire January 09, 2026 LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria”

Industrial Gases Market worth $126,526.8 million by 2030 at 5.1%, says MarketsandMarkets(TM)

Industrial Gases Market worth $126,526.8 million by 2030 at 5.1%, says MarketsandMarkets(TM) GlobeNewswire January 09, 2026 Delray Beach, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) — In terms of value, the Industrial Gases Market projected to be worth USD 126,526.8 million by 2030, registering a CAGR of 5.1%, as per the recent study by MarketsandMarkets(TM). The

Shopley Announces Steve Levely as Chief Executive Officer

Shopley Announces Steve Levely as Chief Executive Officer GlobeNewswire January 09, 2026 TORONTO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Shopley Inc. (the “Company” or “Shopley“), an interactive commerce solution provider for merchants and merchant services providers, is pleased to announce the appointment of Mr. Steve Levely to the position of Chief Executive Officer. The appointment

Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results

(NYSE:CBT), BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced that it will release operating results for the first quarter of fiscal 2026 on Tuesday, February 3, 2026, after the market close. The Company will host a conference call and live webcast to review the first quarter results beginning at 8:00

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF(R) Largest Contributor to Q4 Growth

(NASDAQ:HRTX), CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth quarter and full-year 2025 net revenue. “We are encouraged by the growth in Q4 2025, driven in particular by the momentum in our Acute Care franchise with ZYNRELEF(R)

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF(R) Largest Contributor to Q4 Growth

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF(R) Largest Contributor to Q4 Growth GlobeNewswire January 09, 2026 CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth quarter and full-year 2025 net revenue. “We are

Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results

Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results GlobeNewswire January 09, 2026 BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced that it will release operating results for the first quarter of fiscal 2026 on Tuesday, February 3, 2026, after the market close. The Company will host a conference

Scroll to Top